Yoshifumi Takei

A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics

Yoshifumi Takei, Kenji Kadomatsu, Yukio Yuzawa et al. · Cancer Research · 2004 · 381 citations · Full text

Medicine, Cancer Biology, Oncology +17

Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells.

Yoshifumi Takei, Kenji Kadomatsu, Seiichi Matsuo et al. · PubMed · 2001 · 140 citations

Medicine, Cancer Biology, Oncology +17

The use of granulocyte-colony stimulating factor induced mobilization for isolation of dental pulp stem cells with high regenerative potential

Masashi Murakami, Hiroshi Horibe, Koichiro Iohara et al. · Biomaterials · 2013 · 123 citations · Full text

Dentistry, Oral Biology, Cell Therapy +14

Lymphatic vessels develop during tubulointerstitial fibrosis

Izumi Sakamoto, Yasuhiko Ito, Masashi Mizuno et al. · Kidney International · 2009 · 109 citations · Full text

Medicine, Pathobiology, Pathology +14

The Metastasis-Associated microRNA miR-516a-3p Is a Novel Therapeutic Target for Inhibiting Peritoneal Dissemination of Human Scirrhous Gastric Cancer

Yoshifumi Takei, Misato Takigahira, Keichiro Mihara et al. · Cancer Research · 2010 · 98 citations · Full text

Medicine, Cancer Biology, Oncology +17